[go: up one dir, main page]

MX2015007097A - Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer. - Google Patents

Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.

Info

Publication number
MX2015007097A
MX2015007097A MX2015007097A MX2015007097A MX2015007097A MX 2015007097 A MX2015007097 A MX 2015007097A MX 2015007097 A MX2015007097 A MX 2015007097A MX 2015007097 A MX2015007097 A MX 2015007097A MX 2015007097 A MX2015007097 A MX 2015007097A
Authority
MX
Mexico
Prior art keywords
pyrazines
pyridines
cancer
novel
treatment
Prior art date
Application number
MX2015007097A
Other languages
English (en)
Inventor
Zhanling Cheng
Xingchun Han
Min Jiang
Jianhua Wang
Min Wang
Song Yang
Chengang Zhou
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2015007097A publication Critical patent/MX2015007097A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención proporciona nuevos compuestos que tienen la fórmula general: (ver Fórmula) en donde R1, R2 y R3 son como se describe en la presente, composiciones que incluyen los compuestos y métodos para utilizar los compuestos.
MX2015007097A 2012-12-10 2013-12-06 Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer. MX2015007097A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2012/086275 2012-12-10
PCT/EP2013/075751 WO2014090692A1 (en) 2012-12-10 2013-12-06 Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer

Publications (1)

Publication Number Publication Date
MX2015007097A true MX2015007097A (es) 2015-09-29

Family

ID=49713100

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007097A MX2015007097A (es) 2012-12-10 2013-12-06 Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.

Country Status (10)

Country Link
US (1) US20150266878A1 (es)
EP (1) EP2928893A1 (es)
JP (1) JP2016501251A (es)
KR (1) KR20150092279A (es)
BR (1) BR112015008037A2 (es)
CA (1) CA2885392A1 (es)
HK (1) HK1213544A1 (es)
MX (1) MX2015007097A (es)
RU (1) RU2015124917A (es)
WO (1) WO2014090692A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9862717B2 (en) * 2014-08-22 2018-01-09 Merck Patent Gmbh Indazoles
CN104610229B (zh) * 2015-01-21 2017-01-18 上海皓元生物医药科技有限公司 一种是atp竞争性小分子akt抑制剂a443654的合成方法
KR20180073600A (ko) 2015-11-03 2018-07-02 루 라이센스 에이비 과증식성 장애의 치료를 위한 화합물
ES3004107T3 (en) 2017-01-30 2025-03-11 Univ Kyoto Novel compound, and method for producing regulatory t cells
JP7285249B2 (ja) 2017-10-02 2023-06-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｄｋ８／ｃｄｋ１９阻害剤としての新規な［１，６］ナフチリジン化合物及び誘導体
US11547712B2 (en) 2017-11-20 2023-01-10 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
WO2019136320A1 (en) 2018-01-05 2019-07-11 Icahn School Of Medicine At Mount Sinai Method of increasing proliferation of pancreatic beta cells, treatment method, and composition
CN112135613A (zh) 2018-03-20 2020-12-25 西奈山伊坎医学院 激酶抑制剂化合物和组合物及使用方法
CN112218849B (zh) * 2018-04-06 2023-08-18 巴斯夫欧洲公司 用于制备胺的方法
CN113508111A (zh) * 2018-12-31 2021-10-15 西奈山伊坎医学院 激酶抑制剂化合物和组合物及使用方法
US20210147441A1 (en) * 2019-09-26 2021-05-20 Agency For Science, Technology And Research (A*Star) Therapeutic compounds and methods of use thereof
WO2021263129A1 (en) * 2020-06-26 2021-12-30 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
US20240400993A1 (en) 2021-09-27 2024-12-05 Kyoto University Method for producing t cell
WO2023095801A1 (ja) 2021-11-24 2023-06-01 レグセル株式会社 ヒト誘導性制御性ｔ細胞およびその作製方法
CN118591379A (zh) 2021-11-24 2024-09-03 雷格细胞股份有限公司 用于治疗或预防t细胞相关疾病的药物组合物
JPWO2023182328A1 (es) 2022-03-23 2023-09-28
CN120112629A (zh) 2022-09-26 2025-06-06 国立大学法人京都大学 T细胞产生方法
JPWO2024071039A1 (es) 2022-09-26 2024-04-04
WO2024128741A1 (en) * 2022-12-12 2024-06-20 Avelos Therapeutics Inc. Substituted heterocyclic compound derivatives and their pharmaceutical use
CN120676951A (zh) 2023-02-08 2025-09-19 雷格细胞股份有限公司 用于治疗或预防天疱疮的药物组合物
WO2024204553A1 (ja) 2023-03-29 2024-10-03 レグセル株式会社 ヒト誘導性制御性ｔ細胞およびその作製方法、およびｔ細胞関連疾患を治療または予防するための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2530389A1 (en) * 2003-07-02 2005-01-13 Biofocus Discovery Limited Pyrazine and pyridine derivatives as rho kinase inhibitors
US20090196912A1 (en) * 2004-07-30 2009-08-06 Gpc Botech Ag Pyridinylamines
ZA200704888B (en) * 2004-11-22 2009-02-25 Vertex Pharma Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
DE602006016455D1 (de) * 2005-09-09 2010-10-07 Schering Corp Neue 4-cyano-, 4-amino-, und 4-aminomethylderivative von pyrazoloä1,5-aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h-indazolverbindungen und 5-cyano-, 5-amino- und 5-aminomethylderivative von imidazoä1,2-aüpyridinen, und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase
WO2009117156A1 (en) * 2008-03-21 2009-09-24 Amgen Inc. Pyrazolo-pyrazinone compounds and methods of use thereof

Also Published As

Publication number Publication date
US20150266878A1 (en) 2015-09-24
EP2928893A1 (en) 2015-10-14
KR20150092279A (ko) 2015-08-12
RU2015124917A (ru) 2017-01-12
BR112015008037A2 (pt) 2017-07-04
JP2016501251A (ja) 2016-01-18
HK1213544A1 (zh) 2016-07-08
CA2885392A1 (en) 2014-06-19
WO2014090692A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
MX2015007097A (es) Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.
IN2014DN09346A (es)
PH12017502141A1 (en) Compounds and their methods of use
PH12015500263A1 (en) New bicyclic derivatives
MX358376B (es) Nuevos derivados dihidroquinolina-2-ona.
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
MX2015001720A (es) Hetero-azepinonas sustituidas.
MX2016006432A (es) Tetrahidro-benzodiazepinonas.
PH12014500584A1 (en) New bicyclic dihydroquinoline-2-one derivatives
PH12014500814A1 (en) New aryl-quinoline derivatives
MX2015001099A (es) Nuevos derivados biciclicos de piridina.
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
PH12014502032A1 (en) Treatment of brain cancer
PH12015501088A1 (en) Dimeric compounds
PH12015501038A1 (en) Inhibitors of iap
GB201209587D0 (en) Therapeutic compounds
PH12015500399A1 (en) Azaindolines
MX2015009377A (es) Compuestos radiomarcados.
MX2013013021A (es) Nuevos compuestos de hexahidropirroloimidazolona.
IN2013DE03592A (es)